Stay updated on Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows a new site revision label: Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates an internal platform update rather than changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T11:46:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3 to reflect the latest page version. This indicates an incremental update to the page's version metadata rather than a content change.
    Difference
    0.0%
    Check dated 2026-07-04T03:50:09.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2. This indicates a newer build of the page and does not change the study content.
    Difference
    0.0%
    Check dated 2026-06-26T22:59:04.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page now indicates that no participants are being recruited ('No longer looking for participants'). New navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was adjusted, and the revision version was updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T13:30:57.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Results for SITISVEAL (NCT05542342) were posted on 2026-06-01, updating the study record with the results submission date and extended follow-up and imaging schedules after treatment initiation. The update also references the predefined outcomes (ORR, PFS, OS) used to measure treatment efficacy.
    Difference
    8%
    Check dated 2026-06-05T10:10:57.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page's revision level updated from v3.5.3 to v3.5.4, signaling a small internal update to the page. No user-visible content or trial data changes are introduced by this revision.
    Difference
    0.1%
    Check dated 2026-05-15T02:28:51.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.